MONITORING OF OSTEOPOROSIS TREATMENT
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 9
Abstract
Osteoporosis is far the most common metabolic bone disease and is often called the "silent" disease, because bone loss occurs without symptoms. People often don't know they have the disease until bone breaks, following trivial injury. The consequences of osteoporosis are financial, physical, and psychosocial, which significantly affect the individual as well as the family and community. Osteoporosis bone fractures are responsible for considerable pain, decreased quality of life, lost workdays, and disability. Notably, one in five patients is no longer living one year after sustaining an osteoporotic hip fracture. It is projected that the number of hip fractures worldwide will exceed six million by 2050. These facts make osteoporosis a critical health issue and entire world focus has shifted on to osteoporotic fractures. Dual Energy X-ray Absorptiometry (DEXA) has become standard method for determining bone marrow density. By measuring BMD, it is possible to predict fracture risk in the same manner that measuring blood pressure can help predict the risk of stroke. Approximately 10 -15% of patients with osteoporosis fail to respond to treatment. As in most chronic diseases, compliance is usually poor in patients on long term treatment of osteoporosis. Thus, the aim of monitoring should be to increase adherence to treatment as well as to ascertain response to treatment. Because fracture events are uncommon, they cannot be used to monitor drug effectiveness. Repeat BMD measurement especially at the spine, is recommended once every two years to confirm treatment response.
Authors and Affiliations
Ramesh Narula , Tauseef Mujtaba , Aftab Iraqi , Anjana Arya
Keywords
Related Articles
- EP ID EP98097
- DOI -
- Views 107
- Downloads 0
FORMULATION AND IN VITRO EVALUATION OF LOVASTATIN BUCCAL TABLETS
The present investigation is concerned with formulation and in-vitro evaluation of mucoadhesive buccal tablets containing anticholesteremic agent. Lovastatin to by-pass the first pass effect and to improve its bio availa...
A NOVEL VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF ITOPRIDE HYDROCHLORIDE IN BULK AND PHARMACEUTICAL TABLET DOSAGE FORMS
A simple, specific, accurate, rapid, inexpensive isocratic Reversed Phase-High Performance Liquid Chromatography (RP-HPLC) method was developed and validated for the quantitative determination of Itopride HCl in pharmace...
TRIPHALA: ENVISIONING ITS ROLE IN DENTISTRY
Triphala is an important rasayana drug, used since time immemorial and described in the Ayurveda as a “tridoshic rasayana” (Charka 1500 BC), having balancing and rejuvenating effects on the three constitutional elements...
EVALUATION OF HEAVY METALS IN ETHANOLIC LEAF EXTRACT OF ACACIA CATECHU AS INDICATOR OF POLLUTION BY ATOMIC ABSORPTION SPECTROPHOTOMETRIC (FAAS) ANALYSIS
Acacia catechu ethanolic leaf extract were selected to determine their heavy metals content and thereby to assure their safer therapeutic application. The trace and heavy metals were detected through atomic absorption sp...
FERMENTATION, MEDIA OPTIMIZATION STUDIES FOR COENZYME Q10 PRODUCTION BY Saccharomyces cerevisiae
To establish the fermentation process for CoQ10 production by using Saccharomyces cerevisiae with subsequent bioprocess media optimization studies. Coenzyme Q10 (CoQ10) is a vitamin-like nutrient that plays a vital role...